Quick Answer
Citius Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 18.07 million shares for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed an increase of +149.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Citius Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 0.4%.
- Historical annual values: Fiscal year 2025: 18.07 million shares | Fiscal year 2024: 7.25 million shares | Fiscal year 2023: 6.35 million shares | Fiscal year 2022: 146.21 million shares | Fiscal year 2021: 145.98 million shares | Fiscal year 2020: 55.58 million shares | Fiscal year 2019: 28.93 million shares | Fiscal year 2018: 16.20 million shares | Fiscal year 2017: 8.35 million shares | Fiscal year 2016: 4.88 million shares | Fiscal year 2015: 34.12 million shares | Fiscal year 2014: 30.03 million shares | Fiscal year 2013: 18.00 million shares | Fiscal year 2012: 18.00 million shares | Fiscal year 2011: 18.00 million shares | Fiscal year 2010: 18.00 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: